INTRODUCTION
============

Patent ductus arteriosus (PDA) is a congenital anomaly involving the proximal descending thoracic aorta and is associated with increased morbidity and mortality in preterm infants. In particular, symptomatic PDA adversely affects the regional blood flow, resulting in necrotizing enterocolitis (NEC), particularly in very low birth weight (VLBW) infants. Therefore, PDA frequently requires surgical treatment. The first surgical ligation for PDA was performed by Drs. Gross and Hubbard in 1938, and this operation opened a new era of pediatric cardiac surgery \[[@b1-kjtcv-47-444]\].

In utero, the ductus arteriosus shunts mostly right to left due to the high resistance of the pulmonary circulation. In the first several hours after birth, closure of the ductus arteriosus usually occurs due to increased arterial oxygen tension, which constricts the smooth muscle cells of the ductus. The ductus arteriosus closes spontaneously during the first four days after birth in 90% to 95% of full-term infants and 80% to 90% of premature infants born at 30 to 37 weeks of gestational age (GA) \[[@b2-kjtcv-47-444]\]. However, the rate of spontaneous ductus arteriosus closure is inversely proportional to birth weight. In particular, in VLBW infants, the closure of the ductus arteriosus is often delayed or fails altogether because of an increase in prostaglandin E1 in the blood. This failure results in a persistent left-to-right shunt.

PDA increases the risk of prolonged ventilation, pulmonary edema, pulmonary hemorrhage, and bronchopulmonary dysplasia (BPD). Additionally, the comorbidities associated with PDA include NEC, intestinal ischemia, renal hypoperfusion, retinopathy, cerebral hypoperfusion, and intraventricular hemorrhage (IVH) \[[@b3-kjtcv-47-444]\].

Although PDA ligation is a definitive treatment, there are few comparisons between early surgical ligation and conservative management for symptomatic PDA in the available literature. Prompt ductal closure is desirable to minimize the deleterious effects of PDA in preterm infants. However, the benefits or side effects of surgical ligation in preterm infants remain unclear.

Gerhardt and Bancalari \[[@b4-kjtcv-47-444]\] demonstrated that the surgical closure of PDA decreased the need for ventilatory support and the incidence of significant pulmonary morbidity. Cassady et al. \[[@b5-kjtcv-47-444]\] reported that early prophylactic ligation of PDA in preterm infants reduced the incidence of NEC. Perez et al. \[[@b6-kjtcv-47-444]\] demonstrated that PDA ligation was technically feasible and safe, even in premature, low birth weight infants. Finally, Little et al. \[[@b7-kjtcv-47-444]\] reported that delaying surgical ligation could increase the likelihood of developing morbidity and mortality.

In this context, we aimed to evaluate the efficacy and safety of early surgical ligation (within 15 days of age) over late surgical ligation (after 15 days of age) by a comparative analysis of VLBW infants undergoing surgical correction for symptomatic PDA during a 6-year period at Hanyang University Seoul Hospital.

METHODS
=======

1) Study populations
--------------------

We retrospectively reviewed all the medical records of the neonatal intensive care unit (NICU) at Hanyang University Seoul Hospital, from March 2007 to May 2013, in order to identify VLBW infants ( \< 1,500 g) who underwent surgical PDA ligation. Infants manifesting other congenital anomalies or congenital heart diseases and 3 infants who died within 15 days of birth were excluded.

A total of 320 VLBW infants have been treated in the NICU during the study period, and of them, 125 patients (39.1%) were diagnosed with symptomatic PDA. Excluding 61 patients who improved by medical treatment alone, in the end, 64 patients who underwent surgical correction for symptomatic PDA were enrolled in our study. Of these patients, 28 patients underwent surgical ligation at 15 days of age or earlier (EL group), whereas 36 patients underwent surgical ligation at 16 days of age or later (LL group) ([Fig. 1](#f1-kjtcv-47-444){ref-type="fig"}).

2) Definitions
--------------

Symptomatic PDA indicated hemodynamically significant PDA, which was defined as tachycardia with a heart rate of 160 bpm or more, hyperdynamic precordium, murmur (≥grade II), worsening of the respiratory status, and cardiomegaly on a simple chest X-ray. Symptomatic PDA was defined as the ductus arteriosus having a diameter of 2 mm or more and a ratio of 1.5 or more of the size of the left atrium to the diameter of the aortic root on portable echocardiography (HD11 Diagnostic Ultrasound Imaging System and Transducers; Philips Ultrasound, Bothell, WA, USA).

BPD was defined using Jobe and Bancalari's criteria \[[@b8-kjtcv-47-444]\]. Sepsis was defined as the presence of at least one positive blood culture and clinical manifestations of infection. NEC was classified using Bell's modified staging criteria \[[@b9-kjtcv-47-444]\]. The stages of retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, were defined by the International Classification of Retinopathy of Prematurity \[[@b10-kjtcv-47-444]\]. IVH was classified using Volpe's grading system \[[@b11-kjtcv-47-444]\].

3) Medical treatment
--------------------

Most of the patients were initially treated with 2 to 3 cycles of indomethacin or ibuprofen. In most of the patients, indomethacin or ibuprofen was initially administered according to the treatment protocols as shown in [Table 1](#t1-kjtcv-47-444){ref-type="table"}, unless there were contraindications including poor urine output ( \< 0.6 mL/kg/hr), high blood urea ( \> 30 mg/dL), high serum creatinine ( \> 1.8 mg/dL), thrombocytopenia ( \< 60,000/mm^3^), gastrointestinal bleeding, or intraventricular hemorrhage. Since 2009, our policy for medical treatment of symptomatic PDA has been changed from indomethacin to ibuprofen on the basis of the clinical evidence that ibuprofen is significantly less associated with the impairment of renal function, than indomethacin \[[@b12-kjtcv-47-444],[@b13-kjtcv-47-444]\].

4) Surgery
----------

The indications for surgical ligation include failure or contraindications of medical treatment and the occurrence of hemodynamic instability despite their use. All patients underwent surgical ligations in the NICU under general anesthesia. A left minimal transaxillary thoracotomy, via the 3rd or 4th intercostal space, was performed, and the ductus arteriosus was ligated using a single medium-sized titanium Horizon clip (Teleflex Medical, Research Triangle Park, NC, USA).

5) Data collection
------------------

All the patients' baseline characteristics including GA, birth weight, sex, Apgar score (at 1 minute and 5 minutes), maternal age, the use of ibuprofen, the first day of symptomatic PDA, duration of intubation before surgery, age at surgery, weight at surgery, antenatal steroid treatment, surfactant use, and echocardiographic findings such as size of the PDA and the left atrial-to-aortic root diameter were retrospectively reviewed. Additionally, data concerning preoperative comorbidity such as pulmonary hemorrhage, upper gastrointestinal hemorrhage, pneumothorax, acute respiratory distress syndrome, and IVH were also collected ([Tables 2](#t2-kjtcv-47-444){ref-type="table"}--[4](#t4-kjtcv-47-444){ref-type="table"}). The early clinical outcomes included early mortality and morbidity, such as BPD, sepsis, NEC, prolonged parenteral nutrition ( \> 28 days), retinopathy of prematurity (ROP; stage ≥3), periventricular leukomalacia (PVL), and prolonged length of hospital stay ([Fig. 2](#f2-kjtcv-47-444){ref-type="fig"}).

6) Statistical analysis
-----------------------

Categorical variables were expressed as numbers and percentages and compared using Pearson's χ^2^ test or Fisher's exact test. Continuous variables were reported as means±standard deviations and compared using the Student unpaired t-test or the Mann--Whitney U-test, as appropriate. The odds ratios of early ligation to late ligation affecting the clinical outcomes were obtained through a logistic regression analysis. Statistical significance is denoted by p-values \< 0.05. PASW SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA) was used to perform the statistical analysis.

RESULTS
=======

As shown in [Tables 2](#t2-kjtcv-47-444){ref-type="table"} and [3](#t3-kjtcv-47-444){ref-type="table"}, the GA in the LL group was significantly lower than in the EL group (27.1±2.2 weeks vs. 25.7±1.6 weeks, p=0.010). The other baseline characteristics and preoperative conditions did not differ significantly between the two groups. As shown in [Table 4](#t4-kjtcv-47-444){ref-type="table"}, the intubation period before surgery (9.1±4.5 days vs. 18.2±9.4 days, p \< 0.001) and age at surgery (10.2±3.6 days vs. 24.5±7.6 days, p \< 0.001) were significantly different.

The postoperative clinical outcomes of the study patients, including major morbidity and mortality, are illustrated in [Fig. 2](#f2-kjtcv-47-444){ref-type="fig"}. There were no significant differences in BPD, sepsis, or mortality between the EL and the LL groups. The incidence of ROP was significantly different before adjusting for GA, but after adjusting for GA, it was not significantly different (p=0.163). However, the LL group was significantly associated with an increased risk of NEC (odds ratio, 0.25; p=0.037) and with a prolonged duration of the total parenteral nutrition (TPN) (odds ratio, 0.23; p=0.046) after adjusting for GA.

No infants died during the surgical procedures. Two patients required reoperation due to residual PDA, as diagnosed by postoperative transthoracic echocardiography.

DISCUSSION
==========

Our results indicated that the incidence of NEC and the duration of TPN were significantly decreased in premature infants with early surgical ligation of symptomatic PDA that was refractory to medical treatment. We did not find evidence that late ligation was associated with BPD, sepsis, ROP, PVL, or mortality.

The number of cases of NEC (grade ≥ 2) and the duration of TPN ( ≥ 28 days) in the EL group were reduced compared with those in the LL group. In the present study, this finding could have occurred because the GA in the EL group was significantly older than in the LL group. PDA closure has been inversely correlated with GA. However, after adjusting for GA, the adjusted p values for NEC and the duration of TPN were still less than 0.05, indicating that the incidence of NEC and the duration of TPN were significantly decreased in the EL group.

In the category of perinatal factors, GA in the EL group was significantly longer than that in the LL group. GA was associated with the course of PDA closure, including clinical closure and anatomical closure. With clinical closure in premature infants, constriction of the sensitive smooth muscle cells of the ductus is decreased because of the low response to oxygen and the high sensitivity to prostaglandin E1 and nitric oxide \[[@b14-kjtcv-47-444],[@b15-kjtcv-47-444]\]. During anatomical closure in VLBW infants, hypoxia and immaturity of the ductal closure mechanism interfere with closure progress. Thus, the possibility of the reopening of the ductus arteriosus is high after successful clinical closure in lower GA groups, such as the LL group \[[@b16-kjtcv-47-444]\].

PDA is a common problem in preterm infants and has been associated with increased hospital morbidity and mortality \[[@b17-kjtcv-47-444]\]. In premature infants, PDA increased the risk of prolonged ventilation and resulted in oxygen requirements, as well as increased rates of BPD \[[@b18-kjtcv-47-444]\] and pulmonary hemorrhage \[[@b19-kjtcv-47-444]\]. However, in the present study, there were no significant differences in BPD between the EL and the LL groups. The diastolic steal of blood flow through the PDA has been associated with intestinal ischemia, renal hypoperfusion, NEC, reduced middle cerebral artery blood flow velocity \[[@b20-kjtcv-47-444]\], and an increased risk of IVH \[[@b21-kjtcv-47-444]\]. In particular, impaired intestinal blood flow can cause feeding intolerance and NEC, and a previous study confirmed that the early prophylactic ligation of PDA in VLBW infants reduced the incidence of NEC \[[@b5-kjtcv-47-444]\]. In our study, we concluded the early surgical ligation for the treatment of PDA might be desirable to reduce the incidence of NEC and to improve feeding intolerance in preterm infants.

Medical treatment has proven to be the initial choice of therapy. However, there have been side effects such as renal impairment, IVH, and NEC \[[@b22-kjtcv-47-444]\]. Surgical treatment has been recommended after initial medical treatment has failed or has been contraindicated because there have also been complications with surgical closure, such as cardiopulmonary dysfunction, chylothorax, vocal cord and diaphragmatic paralysis, infection, unstable blood pressure, and death \[[@b23-kjtcv-47-444],[@b24-kjtcv-47-444]\].

In VLBW infants with hemodynamically significant PDA, the decision for the optimal timing of surgical closure is important \[[@b25-kjtcv-47-444]\]. However, there have been few reports comparing early surgical ligation and late surgical ligation for symptomatic PDA. Tantraworasin et al. \[[@b26-kjtcv-47-444]\] demonstrated that the surgical closure of PDA in premature infants was safe, but early ligation did not appear to be more beneficial than late ligation. These authors defined the early surgery group as infants operated upon within 21 days after birth. In contrast, Lee et al. \[[@b3-kjtcv-47-444]\] reported that early PDA closure in extremely low birth weight infants ( \< 1,000 g) by either medical or surgical treatment, was necessary within the first week of life. Additionally, Hsiao et al. \[[@b27-kjtcv-47-444]\] reported that early ligation (within 14 days of birth) of medically refractory PDA in VLBW infants ( \< 1,500 g) improved enteral feeding tolerance and reduced TPN and ventilator use. These findings are consistent with those of our study. Additionally, two previous studies demonstrated that prolonged medical therapy before PDA ligation increased hospital morbidity and hospital stays. The authors of these studies recommended that early PDA ligation be performed as soon as medical treatment was unsuccessful \[[@b17-kjtcv-47-444],[@b25-kjtcv-47-444]\]. In our study, the surgical closure of PDA was safe in preterm infants, and early ligation appeared to be more beneficial than late ligation.

To diagnose symptomatic PDA earlier, it is very important to perform echocardiography within the first 24 hours after birth. Furthermore, for early PDA closure, it is important to confirm the response to treatment by echocardiography \[[@b28-kjtcv-47-444]\]. Teamwork and cooperation between cardiac surgeons and neonatologists are absolutely necessary to optimize the clinical course of the patient through optimal planning of the ideal timing for surgical ligation.

In addition, according to the policy of our hospital, postoperative echocardiography for all the operated infants was performed in the NICU immediately after surgery and two infants were re-operated upon to close the PDA completely as soon as they were diagnosed by postoperative echocardiography, with the maintenance of general anesthesia.

We performed a retrospective study; it was not possible to perform a randomized, controlled trial. The number of subjects was limited by the appearance of VLBW infants with symptomatic PDA who were refractory to medical treatment not being frequent during the study period. The long-term outcomes, positive and negative, must be evaluated further. Additionally, future studies are required to determine whether the potential benefits of the surgical closure of the ductus arteriosus are balanced against the possible side effects of the surgical procedure.

In conclusion, early surgical ligation for the treatment of PDA that failed to close after medical treatment or in cases contraindicated for medical treatment might be desirable, to reduce the incidence of NEC and to improve feeding intolerance in preterm infants.
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###### 

Protocol for indomethacin and ibuprofen treatment

  Age at 1st dose                                                     1st   2nd    3rd
  ------------------------------------------------------------------- ----- ------ ------
  Indomethacin (mg/kg)[a)](#tfn1-kjtcv-47-444){ref-type="table-fn"}                
   \< 48 hr                                                           0.2   0.1    0.1
   2--7 day                                                           0.2   0.2    0.2
   \> 7 day                                                           0.2   0.25   0.25
  Ibuprofen (mg/kg)[b)](#tfn2-kjtcv-47-444){ref-type="table-fn"}      10    5      5

At 12--24-hour intervals.

At 24-hour intervals.

###### 

Baseline characteristics of the study patients

  Variable                        Early ligation group (n=28)   Late ligation group (n=36)   p-value
  ------------------------------- ----------------------------- ---------------------------- ---------
  Gestational age (wk)            27.1±2.2                      25.7±1.6                     0.010
  Birth weight (g)                883±190                       817±188                      0.17
  Male gender (%)                 15 (53.6)                     15 (41.7)                    0.45
  Apgar score at 1 min            1.8±0.9                       1.6±1.2                      0.51
  Apgar score at 5 min            3.9±1.2                       3.2±1.5                      0.06
  Antenatal steroid (%)           18 (64.2)                     26 (72.2)                    0.57
  Maternal age (yr)               31.4±2.9                      30.7±3.2                     0.38
  Surfactant use (%)              27 (96.4)                     36 (100.0)                   0.44
  Length of hospital stay (day)   98.1±54.8                     94.0±26.0                    0.70

Values are presented as mean±standard deviation or number (%).

###### 

Preoperative conditions of the study patients

  Variable                              Early ligation group (n=28)   Late ligation group (n=36)   p-value
  ------------------------------------- ----------------------------- ---------------------------- ---------
  Pulmonary hemorrhage                  5 (17.9)                      10 (27.8)                    0.39
  Upper gastrointestinal hemorrhage     4 (14.3)                      8 (22.2)                     0.53
  Pneumothorax                          1 (3.6)                       0                            0.07
  Acute respiratory distress syndrome   13 (46.4)                     22 (61.1)                    0.31
  Intraventricular hemorrhage           13 (46.4)                     17 (47.2)                    1.00
  Ibuprofen use                         14 (50)                       17 (47.2)                    0.34

Values are presented as number (%).

###### 

Operative conditions of the study patients

  Variable                                            Early ligation group (n=28)   Late ligation group (n=36)   p-value
  --------------------------------------------------- ----------------------------- ---------------------------- ----------
  First day of symptomatic patent ductus arteriosus   3.1±2.1                       3.8±2.6                      0.24
  Intubation before surgery (day)                     9.1±4.5                       18.2±9.4                     \< 0.001
  Age at surgery (day)                                10.2±3.6                      24.5±7.6                     \< 0.001
  Weight at surgery (g)                               839.2±193.1                   892.2±298.3                  0.42
  Patent ductus size (mm)                             2.4±0.7                       2.2±0.8                      0.21
  Left atrial/aortic diameter (mm)                    1.5±0.3                       1.5±0.4                      0.67

Values are presented as mean±standard deviation.
